SCHEMBL12020288

SCHEMBL12020288

[C-]#[N+]c1c(N)nc(SCc2coc(-c3ccc(C)cc3)n2)c(C#N)c1-c1ccc(OCC2COC(C)(C)O2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 14/20 0.42
▸ ADORA2B P29275 8/20 0.39
▸ SLC6A3 Q01959 1/20 0.38
▸ ADORA2A P29274 3/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12020322 0.95 ADORA1 (0.44) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12020303 0.95 ADORA1 (0.44) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12020312 0.95 ADORA1 (0.44) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12535013 0.94 ADORA1 (0.43) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12534939 0.92 ADORA1 (0.40) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12535009 0.92 ADORA1 (0.40) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12534966 0.92 ADORA1 (0.39) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12534970 0.92 ADORA1 (0.39) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12534890 0.91 ADORA1 (0.39) ADORA1ADORA2BSLC6A3ADORA2AADORA3
SCHEMBL12534879 0.91 ADORA1 (0.45) ADORA1ADORA2BSLC6A3ADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741834-B2 Dipeptoid prodrugs and the use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-06-03 — — US disclosed
US-20110294719-A1 DIPEPTOID PRODRUGS AND THE USE THEREOF Bayer Schering Pharma 2011-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294719-A1 DIPEPTOID PRODRUGS AND THE USE THEREOF DPP4, DPP3, DNPEP ADORA1 1562/4885ADORA2B 1900/4885SLC6A3 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback